Pharmacy Expert Shares Insights On Readytouse Cytotoxic Drugs | Latest News RSS feed
Pharmacy Expert Shares Insights On Readytouse Cytotoxic Drugs - Latest News
A quest to drug the undruggable
Trump's Prescription Drug Price Controls Would Save Us Money. They Would Also Make Us Sicker.
Last January, President Trump declared that pharmaceutical companies are "getting away with murder" by pricing their drugs too high. "Pharma has a lot of lobbies, a lot of lobbyists, and a lot of powe... read more
The U.S. May Ban Kratom. But Are its Effects Deadly or Lifesaving?
The rising number of kratom users has alarmed states like Vermont, Wisconsin and four others that have already banned the drug. Ohio may soon join that list, following a recommendation from the state’ ... read more
Looking for another news?
Targeting the mechanisms that allow leukaemia to thrive
they targeted Tim-3 on the surface of AML cells with bespoke gold nanoparticles loaded with a cytotoxic drug called rapamycin. They saw that the drug was internalised within the cell and it perturbed ... read more
New Funding to Significantly Boost Cancer, ALS Research
delivering a cytotoxic selectively and directly to EphA3-expressing cancer cells. Pellecchia will collaborate with Heba F. Salem, a professor of pharmaceutics and drug delivery, and the dean of the fa... read more
HMS Holdings (HMSY) Q2 2018 Results - Earnings Call Transcript
This quick response capability was evident again in the second quarter, as Eliza completed a special project, handling outreach on behalf of a large national pharmacy chain for a drug recall ... Jeff, ... read more
How Alberta is cracking down on the Hells Angels and the outlaw gangs that support ...
Based on research compiled by independent experts on law enforcement and interviews with police ... Since central Alberta alone didn’t have the drug market to sustain the club, members were allowed to ... read more
FDA approves first MS treatment in pill form
The Food and Drug Administration (FDA) has approved the first oral drug for treating relapsing-remitting multiple sclerosis (MS), the most common form of the disease. Unlike current MS drugs, which ar... read more
A Plan For New Antibiotics
incorporating insights and guidance as new research findings emerge. It will take time to determine whether conditional guidelines can be developed for Gram-negative drug entry and efflux avoidance. M... read more
Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal
Research suggests that antibodies blocking the interaction of SIRP-alpha and CD47 receptors can enhance tumour-killing and rejection, in part by activating cytotoxic T lymphocytes (CTL) responses. Oth... read more
What It Takes To Create A Winning Mobile SEO Strategy: 5 Questions With Humana’s Mobile Manager
The current app allows users to view their insurance coverage and claims, search for pharmacies and physicians, review drug pricing, order refills, and enroll in Humana’s mail-order pharmacy service . ... read more
TherapeuticsMD's (TXMD) CEO Robert Finizio on Q4 2016 Results - Earnings Call Transcript
In July, we filed our new drug ... they share their current total compounded E+P Prescriptions which equates to TX-001HR volume as well as additional data points. And then number three, is entering in... read more